Latest
Science & Space

Scientists Develop 'Detangle' Bioelectronic Electric Comb That Stimulates Near-100% Hair Regrowth in Breakthrough Study

Published in Nature Communications, the device delivers pulsed electric fields and therapeutic genetic molecules deep into follicles, dramatically outperforming conventional treatments.

Read the story
Science & Space · Read the story
Newstro Science & Space section banner.
Newstro
Share this story

Bioelectronic system bypasses epidermal barrier to reactivate dormant hair follicles

Beijing, China — November 16, 2026 · 5:00 p.m. CST

In what researchers are describing as a major leap forward in dermatological engineering, an international team of scientists has engineered an electrified bioelectronic comb called "Detangle" that achieved near-100% hair follicle regeneration in preclinical models of pattern baldness, as reported by the Daily Mail, The Independent, and Popular Mechanics.

The study, published in the peer-reviewed scientific journal Nature Communications, addresses the central obstacle that has hindered topical hair loss remedies for decades: the tough outer layer of the scalp, known as the stratum corneum, which blocks more than 95% of active pharmaceutical molecules from reaching the deep hair bulb and follicular stem cell niches.

Led by bioengineers at Beihang University, the research team designed a specialized comb featuring alternating-length microelectrode teeth integrated with miniature drug reservoirs. As users draw the device across the scalp, the varying teeth part the hair strands and deliver synchronized micro-electric pulses that temporarily open microscopic pathways in cell membranes through a process called electroporation—pushing therapeutic genetic payloads up to nine times deeper than conventional topical foams or serums.

Dual genetic delivery: Blocking DHT while stimulating capillary blood flow

Unlike commercial cosmetic laser brushes that rely solely on low-level light photobiomodulation, the Detangle device functions as an active molecular transdermal infusion system.

During experimental trials on mice exhibiting androgenetic alopecia—the biological equivalent of male- and female-pattern baldness—the comb's rolling micro-dispensers released two complementary therapeutic genetic agents:

  • VEGFA plasmid: A gene-encoding molecule that stimulates vascular endothelial growth factor, triggering the rapid growth of microscopic capillary networks around shrunken hair roots to restore vital blood and oxygen supply.
  • SRD5A2 siRNA: A precision short-interfering RNA sequence that silences the gene responsible for synthesizing 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT)—the primary hormone driving follicular miniaturization and baldness.

Over a rigorous 28-day treatment regimen, the electrified comb stimulated comprehensive follicle reactivation, restoring nearly 100% of dense hair coverage across treated areas. In contrast, control cohorts receiving standard 5% topical minoxidil reached only 70% regrowth within the same timeframe, while untreated groups showed negligible recovery.

Human safety trials next step before commercial translation

While the findings published by ScienceAlert have generated immense enthusiasm among dermatologists and millions seeking alternatives to hair transplant surgery, the study's authors emphasized the importance of scientific restraint.

The technology has thus far been validated exclusively in rodent models. Human scalp tissue possesses greater thickness, different follicular density, and complex immunogenic barriers that must be rigorously evaluated in upcoming Phase 1 clinical trials to confirm safety, long-term tolerance, and optimal electrical pulse frequencies.

The research consortium confirmed that it is currently preparing regulatory filings for initial human safety assessments, with clinical dermatological trials targeted to commence late next year.

Beihang University research campus in Beijing

The bioelectronic engineering and molecular delivery research was conducted at Beihang University's advanced biomedical materials laboratories in the Haidian District of Beijing, China.

★ Beihang University, 37 Xueyuan Road, Haidian District, Beijing, China. Map data: OpenStreetMap contributors, ODbL. Open map.

Timeline of the Detangle bioelectronic comb development

  1. — Beihang University materials team begins testing micro-needle arrays for deep dermal drug transport.
  2. — Engineers complete first working prototype of the alternating-tooth electrified comb with integrated micro-reservoirs.
  3. — 28-day controlled comparative animal trials demonstrate 9x enhanced delivery depth and near-100% hair follicle recovery.
  4. — Comprehensive findings peer-reviewed and accepted by Nature Communications editors.
  5. — Study published globally, detailing bioelectronic electroporation for androgenetic alopecia treatment.

Sources and reporting credits

Reporting: Daily Mail, The Independent, Popular Mechanics, Nature Communications, ScienceAlert.

Visuals: Newstro.